HKU Scholars Hub: Browsing DSpace

Browsing by Author Dellinger, A

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中

or enter first few letters:

Showing results 1 to 13 of 13

	Title	Author(s)	Issue Date
	Coffee consumption increases hepatic expression of cytochrome P450S and significantly reduces liver fibrosis in patients with nonalcoholic fatty liver disease (NAFLD) Proceeding/Conference:Journal of Hepatology	Tillmann, H Suzuki, A Pang, HMH Dellinger, A Guy, CD Moylan, CA Piercy, D Smith, M Hauser, MA Diehl, AME	2011
	Coffee's beneficial effect on liver disease confirmed in NASH cohort, but only partially confirmation of in vitro pre-described differentially expressed genes in this patient cohort Proceeding/Conference:Gastroenterology	Tillmann, HL Pang, HMH Dellinger, A Suzuki, A Guy, CD Moylan, CA Piercy, D Smith, M Hauser, MA Diehl, AM Abdelmalek, MF	2011
	Direct Evidence of Target Inhibition with Anti-VEGF, EGFR, and mTOR Therapies in a Clinical Model of Wound Healing Journal:Clinical Cancer Research	Jia, J Dellinger, A Weiss, E Bulusu, A Rushing, C Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H	2015
	Direct Evidence of Targeted Inhibition by Anti-angiogenic Agents from a Wound-healing Model in Patients with Advance Solid Tumors Proceeding/Conference:Targeting VEGF-mediated Tumor Angiogenesis in Cancer Therapy Conference	Jia, J Dellinger, A Weiss, ES Bulusu, A Li, H Howard, L Kaplan, N Pang, HMH Hurwitz, H Nixon, AB	2014
	Epigenetic Regulation of Gene Expression in NAFLD Proceeding/Conference:Gastroenterology	Moylan, CA Yang, H Pang, HMH Dellinger, A Suzuki, A Tillmann, HL Guy, CD Ashley-Koch, AE Garrett, ME Abdelmalek, MF	2012
	Hepatic gene expression profiles differentiate presymptomatic patients with mild versus severe nonalcoholic fatty liver disease Journal:Hepatology	Moylan, CA Pang, HMH Dellinger, A Suzuki, A Garrett, ME Guy, CD Murphy, SK Ashley-Koch, AE Choi, SS Michelotti, G	2014
	Modulation of angiogenic biomarkers in patients receiving high-dose TRC105 Proceeding/Conference:Journal of Clinical Oncology	Liu, Y Starr, M Brady, JC Pang, HMH Dellinger, A Leigh, BR Theuer, CP Hurwitz, H Nixon, AB	2012
	Modulation of circulating protein biomarkers following TRC105 (anti-endoglin antibody) treatment in patients with advanced cancer Journal:Cancer Medicine	Liu, Y Starr, MD Brady, JC Dellinger, A Pang, HMH Adams, B Theuer, CP Lee, NY Hurwitz, HI Nixon, AB	7-Mar-2014
	Modulation of pharmacodynamic (PD) biomarkers in dermal biopsies from patients treated on a phase I study of bevacizumab (Bev) in combination with everolimus (Ev) and erlotinib (Erl) for advanced solid tumors Proceeding/Conference:Journal of Clinical Oncology	Jia, J Li, H Dellinger, A Pang, HMH Russell, KB Hurwitz, H Nixon, AB	2012
	A phase I study of ABT-510 plus bevacizumab in advanced solid tumors Journal:Cancer Medicine	Uronis, HE Cushman, SM Bendell, JC Blobe, GC Morse, MA Nixon, AB Dellinger, A Starr, MD Li, H Meadows, K Gockerman, J Pang, HMH Hurwitz, HI	2013
	Phase I study of capecitabine, oxaliplatin, bevacizumab, and everolimus in advanced solid tumors Journal:Invest New Drugs	Rangwala, F Bendell, JC Kozloff, MF Arrowood, CC Dellinger, A Meadows, J Tourt-Uhlig, S Murphy, J Meadows, KL Starr, A Broderick, S Brady, JC Cushman, SM Morse, MA Uronis, HE Hsu, SD Zafar, SY Wallace, J Starodub, AN Strickler, JH Pang, HMH Nixon, AB Hurwitz, HI	2014
	A Phase I/biomarker study of bevacizumab in combination with CNTO 95 in patients with advanced solid tumors Journal:Cancer Chemotherapy and Pharmacology	Uronis, HE Jia, J Bendell, J Howard, L Ready, NA Lee, PA Starr, MD Dellinger, A Pang, HMH Nixon, AB	2015
	Relationship between methylome and transcriptome in patients with nonalcoholic fatty liver disease Journal:Gastroenterology	Murphy, SK Yang, H Moylan, CA Pang, H Dellinger, A Abdelmalek, MF Garrett, ME Ashley-Koch, A Suzuki, A Tillmann, HL Hauser, MA Diehl, AM	2013

Showing results 1 to 13 of 13